THE ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY YTH-906 IN LIVER-TRANSPLANTATION

被引：0
|
作者：
FRIEND, PJ
WALDMANN, H
COBBOLD, S
TIGHE, H
REBELLO, P
WIGHT, D
GORE, S
POLLARD, S
LIM, S
JOHNSTON, P
WILLIAMS, R
OGRADY, J
CALNE, RY
机构：
[1] UNIV CAMBRIDGE,DEPT PATHOL,MRC BIOSTAT UNIT,CAMBRIDGE CB2 2QQ,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,LIVER UNIT,LONDON SE5 8RX,ENGLAND
来源：
TRANSPLANTATION PROCEEDINGS | 1991年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1390 / 1392
页数：3
相关论文
共 50 条
  • [21] ANTI-CD25 MONOCLONAL-ANTIBODY PREVENTS EARLY REJECTION IN LIVER-TRANSPLANTATION - A PILOT-STUDY
    OTTO, G
    THIES, J
    KABELITZ, D
    SCHLAG, H
    HOFMANN, WJ
    HERFARTH, C
    MEUER, S
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1387 - 1389
  • [22] USE OF A MONOCLONAL-ANTIBODY AGAINST THE T-CELL RECEPTOR FOR PROPHYLACTIC IMMUNOSUPPRESSIVE TREATMENT AFTER LIVER-TRANSPLANTATION
    WONIGEIT, K
    NASHAN, B
    SCHWINZER, R
    SCHLITT, HJ
    KURRLE, R
    RACENBERG, J
    SEILER, F
    RINGE, B
    PICHLMAYR, R
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2258 - 2259
  • [23] ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY THERAPY IN PRIMATE CARDIAC TRANSPLANTATION
    OAKS, TE
    JENNINGS, SR
    LIPPE, PA
    MAGOVERN, JA
    PIERCE, WS
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (01) : 823 - 825
  • [24] More on risk/benefit ratio of anti-IL-2 receptor monoclonal antibodies
    Soulillou, Jean-Paul
    Cantarovich, Diego
    TRANSPLANT INTERNATIONAL, 2010, 23 (12) : 1205 - 1206
  • [25] SYNERGISTIC INHIBITION OF CYTOKINE PRODUCTION, AND PROLONGATION OF RAT RENAL-ALLOGRAFT SURVIVAL BY ANTI-IL-2 RECEPTOR (IL-2R) MONOCLONAL-ANTIBODY (MAB) AND CYCLOSPORINE (CSA)
    HANCOCK, WW
    UEDA, H
    KUPIECWEGLINSKI, J
    TILNEY, N
    KIDNEY INTERNATIONAL, 1990, 38 (03) : 560 - 560
  • [26] ANTI IL-2 RECEPTOR MONOCLONAL-ANTIBODY IN THE STRATEGY FOR THE TREATMENT OR THE PREVENTION OF ACUTE GVHD
    HERVE, P
    WIJDENES, J
    CAHN, JY
    TIBERGHIEN, P
    MILPIED, N
    BORDIGONI, P
    BERGERAT, JP
    RACADOT, E
    LYMPHOKINE RESEARCH, 1990, 9 (04): : 608 - 608
  • [27] COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION WITH ATG OR IL-2 RECEPTOR ANTIBODY
    NEUHAUS, P
    BECHSTEIN, WO
    BLUMHARDT, G
    WIENS, M
    LEMMENS, P
    LANGREHR, JM
    LOHMANN, R
    STEFFEN, R
    SCHLAG, H
    SLAMA, KJ
    LOBECK, H
    TRANSPLANTATION, 1993, 55 (06) : 1320 - 1327
  • [28] PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN IDENTICAL SIBLING DONOR BMT BY ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1
    FERRANT, A
    LATINNE, D
    BAZIN, H
    STRAETMANS, N
    CORNET, A
    DELAPARRA, B
    MICHAUX, JL
    BLOOD, 1994, 84 (10) : A158 - A158
  • [29] CELLS REACTING WITH THE MONOCLONAL ANTI-IL-2 RECEPTOR ANTIBODY AMT-13 IN THE REGENERATING THYMUS OF IRRADIATED MICE
    TAKACS, L
    OSAWA, H
    LISZKA, K
    DIAMANTSTEIN, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1986, 64 (02): : 342 - 347
  • [30] USE OF OKT3 MONOCLONAL-ANTIBODY AS INDUCTION THERAPY FOR CONTROL OF REJECTION IN LIVER-TRANSPLANTATION
    WALL, WJ
    GHENT, CN
    ROY, A
    MCALISTER, VC
    GRANT, DR
    ADAMS, PC
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (01) : 52 - 57
12345